LMS appoints Dr. Marilyn Sue Bogner to Risk and Patient Safety Advisory Board
June 01 2005 - 9:32AM
PR Newswire (US)
LMS appoints Dr. Marilyn Sue Bogner to Risk and Patient Safety
Advisory Board MONTREAL, June 1 /PRNewswire-FirstCall/ -- LMS
Medical Systems (AMEX:LMZ; TSX:LMZ), a healthcare technology
company and developer of the CALM(TM) system (Computer Assisted
Labor Management), today announced the appointment of Dr. Marilyn
Sue Bogner to the LMS Risk and Patient Safety Advisory Board. Dr.
Bogner is President and Chief Scientist with the Institute for the
Study of Human Error. A psychologist specializing in human factors
and medical error, she has advised the U.S. Military, the Agency
for Healthcare Research and Quality (AHRQ) and the FDA. She has
contributed to over 35 books or commissioned reports on human error
in medicine. Her working in identifying serious and persistent
human factors and bringing collaborations to address these issues
has garnered international recognition as well as several
prestigious national achievement awards. She is on the editorial
board of several major peer reviewed journals for medical,
biomedical engineering, and behavioral sciences. Patient safety is
a cornerstone of high quality clinical care yet errors are still
prevalent in healthcare today. Obstetrics is not immune to this. In
fact, studies report that 30 to 50 percent of adverse outcomes in
OB are potentially preventable. Strategies to improve patient
safety traditionally address elements such as skills updates, human
factors and team dynamics. These approaches are most effective when
clinicians have an accurate analysis and understanding of the
problem at hand as well as the consequences of their interventions.
LMS specializes in risk management tools for clinicians and
managers that provide continuous analysis of complex clinical and
electronic monitoring data. The CALM tools incorporate statistical
processes to quantify normal and abnormal labor progression as well
as digital signal processing and neural network applications for
the identification of abnormal fetal heart rate patterns. The CALM
Curve provides for consistent and objective assessment of the labor
progress at the bedside. CALM Patterns provides objective,
real-time measurement and classification of fetal heart rate
patterns. These tools address commonly found root causes of adverse
outcomes such as the failure to recognize and respond to abnormal
tracings and prolonged labor. "Dr. Bogner has pioneered the study
of multiple dimensions of human error in medicine and her guidance
will be most welcome in helping to anticipate challenges,
especially the usability and clarity of the computerized analysis,"
said Dr. Emily Hamilton, Founder and Chief Medical Officer of LMS.
"Her insight into the causes of medical errors will greatly
complement the contributions of other Board members." About LMS:
LMS Medical Systems is a leader in the application of advanced
mathematical modeling and neural networks for medical use. The LMS
Computer Assisted Labor Management product suite provides
physicians, nursing staff and risk managers with innovative
obstetrical decision support and risk management tools integrated
into robust clinical information systems designed to improve
outcomes and patient care for mothers and their infants during
labor and delivery. This press release contains forward-looking
statements that involve risks and uncertainties, which may cause
actual results to differ materially from the statements made. For
this purpose, any statements that are contained herein that are not
statements of historical fact may be deemed to be forward- looking
statements made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Without limiting
the foregoing, the words "believes," "anticipates," "plans,"
"intends," "will," "should," "expects," "projects," and similar
expressions are intended to identify forward-looking statements.
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause actual results, future
circumstances, or events to differ materially from those projected
in the forward-looking statements. These risks include, but are not
limited to, those associated with the success of research and
development programs, the adequacy, timing, and results of clinical
trials, the regulatory approval process, competition, securing and
maintaining corporate alliances, market acceptance of the Company's
products, the strength of intellectual property, financing
capability, the potential dilutive effects of any financing,
reliance on subcontractors and key personnel, and other risks
detailed from time-to-time in the Company's public disclosure
documents or other filings with the Canadian and U.S. securities
commissions or other securities regulatory bodies. The
forward-looking statements are made as of the date hereof, and the
Company disclaims any intention and has no obligation or
responsibility, except as required by law, to update or revise any
forward- looking statements, whether as a result of new
information, future events, or otherwise. DATASOURCE: LMS MEDICAL
SYSTEMS INC. CONTACT: please contact: Andrea Miller,
Communications, LMS Medical Systems Inc., (514) 488-3461, Ext. 222,
Fax: (514) 488-1880, , http://www.lmsmedical.com/
Copyright